Q2-Header_1280x350_2

Clinical Trial Infectious Disease Testing Services

Global Solutions for Infectious Disease Testing and Drug Development

Q2 Solutions offers clinical trial infectious disease testing capabilities for bacterial pathogens and viral infectious agents. We also have the scientific and technical expertise available to work on study specific methodologies and assay developments with our Bioanalytical and Genomics laboratories.

Q2 Solutions has a vaccine laboratory in San Juan Capistrano, CA and an affiliate laboratory in Pretoria, South Africa. In many instances, these centers of excellence work collaboratively on trials depending on the trial location. Our customers have access to a multi-faceted global vaccine laboratory network, where we provide insight into regulations, customs and sample requirements for global, local or regional studies.

Vaccine Laboratory Services Test Menu

View our extensive test menu of standard and custom efficacy and immunogenicity assays for infectious disease testing. Learn more about our clinical trial infectious disease lab and testing capabilities by viewing our assets below.

Learn more
q2lab solutions images_0007_Layer 9

Related Thought Leaders Insights


Harnessing innovative technologies for clinical trials involving emerging and re-emerging infectious diseases

This white paper highlights the challenges of emerging and re-emerging infectious diseases such as TB, MSSA/MRSA, and Ebola.  At Q2 Solutions, we support infectious disease clinical trials with a...

Laboratory Solutions for Hepatitis B (HBV) Clinical Trials

Q2 Solutions’ infectious disease expertise, coupled with that of parent organizations IQVIA and Quest Diagnostics, offers extensive diagnostic testing experience, global CRO expertise and multiple...

Post COVID-19 reboot of clinical trials in Asia Pacific

Dr. Patrice Hugo recently co-authored a white paper with IQVIA about restarting clinical trials in Asia Pacific following the COVID-19 pandemic. The recent restrictions imposed by many countries in...